Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Licensing opportunity from NIH: orally active neuron cell death-inhibitory peptides

Dec. 21, 1999

First human trial of Sheffield's pulmonary delivery system for migraine therapy

Dec. 21, 1999

Add-on stiripentol produces high response rate in intractable epilepsy syndrome

Dec. 20, 1999

New class I mGluR antagonist prevents seizure-induced hippocampal damage

Dec. 20, 1999

Remacemide for resistant epilepsy: preliminary data from meta-analysis

Dec. 20, 1999

PPG superior to nonselective mGluR agonists in audiogenic seizure model

Dec. 20, 1999

Novel dopaminergic agents synthesized and tested at AHP

Dec. 20, 1999

Harkoseride effectively controls status epilepticus, has favorable profile for clinical development

Dec. 17, 1999

Algos discusses NDA for MorphiDex with FDA

Dec. 17, 1999

Preclinical results indicate efficacy for NPS-1776 in various seizure types in humans

Dec. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...